# Clinical Benefits of Aloe vera Gel in 0.3% Hyaluronate Eyedrops in Glaucoma Therapy-Related Ocular Surface Disease

**Authors:** Luca Agnifili, Davide Celani, Alessandro Sferra, Maria Ludovica Ruggeri, Rodolfo Mastropasqua, Michele Figus, Matteo Sacchi

PMC · DOI: 10.3390/biomedicines14010186 · Biomedicines · 2026-01-15

## TL;DR

Aloe vera gel combined with hyaluronate improves eye surface health in patients with glaucoma-related eye issues.

## Contribution

This study demonstrates that Aloe vera gel in hyaluronate eyedrops can effectively treat glaucoma therapy-related ocular surface disease.

## Key findings

- Aloe vera gel with hyaluronate improved tear breakup time and Schirmer test results in patients.
- The treatment reduced symptoms like conjunctival hyperemia and corneal staining significantly.
- Aloe vera gel showed a trend in reducing MMP-9 levels, indicating anti-inflammatory effects.

## Abstract

Background: Aloe vera gel in 0.3% hyaluronate (AV/HA) could mitigate glaucoma therapy-related ocular surface disease (GTOSD). Methods: Thirty-nine patients diagnosed with GTOSD and receiving AV/HA or HA underwent ocular surface disease index (OSDI), Symptom Assessment iN Dry Eye (SANDE), National Eye Institute Visual Function Questionnaire (NEI VFQ)-25 questionnaires, and tear matrix metalloproteinase-9 (MMP-9), break-up time (BUT), corneal fluorescein staining (CFS), Schirmer test I (STI), and bulbar conjunctival hyperemia (BCH) determination. Results: After one month, AV/HA increased BUT (5 (7–4.5) to 7 (8–5.5)) and STI (12 (19.5–8) to 13.5 (20–10)), while it decreased BCH (2.2 (2.3–1.3) to 2.1 (2.2–1.2)) and CFS (3 (4–2) to 2 (3.0–1.5)) (p < 0.001). SANDE and OSDI scores were reduced from 36.18 (38.5–20.5) to 22.91 (31.5–17.21), and 29.5 (32.5–19.5) to 20 (26.5–18) (p < 0.001). HA reduced BCH from 2.75 (3.20–2.15) to 2.25 (2.30–1.90) (p = 0.014) and CFS from 3.5 (5–2.75) to 2.5 (4–2) (p = 0.014), while it increased BUT (p = 0.036). The SANDE score decreased from 28.95 (47.6–20.9) to 26.86 (36.41–19.90) (p = 0.009), whereas the OSDI decreased from 40 (49–19.5) to 29 (42–19.75) (p = 0.005). Any significant change in NEI VFQ-25 was collected. A trend for an MMP-9 immunoassay positivity reduction was observed in AV/HA (0.073). Conclusions: These findings invite considering lubricants enriched with natural anti-inflammatory agents, such as Aloe vera, as a potential adjunctive option to improve the ocular surface in glaucoma.

## Linked entities

- **Proteins:** MMP9 (matrix metallopeptidase 9)
- **Chemicals:** Aloe vera (PubChem CID 5712222)
- **Diseases:** glaucoma (MONDO:0005041)

## Full-text entities

- **Diseases:** GTOSD (MESH:D016609), Ocular Surface Disease (MESH:D010534), BCH (MESH:D003229), Glaucoma (MESH:D005901), inflammatory (MESH:D007249)
- **Chemicals:** Hyaluronate (-), fluorescein (MESH:D019793)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12839199/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12839199/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC12839199/full.md

---
Source: https://tomesphere.com/paper/PMC12839199